Fmr. FDA, CDC Official on Cyclospora, Food Safety Issues
Original Report
Steve Ostroff, Former Acting Commissioner of the FDA and Former Deputy Director of the National Center for Infectious Diseases at the CDC, joined the program to discuss the public awareness timeline...
Steve Ostroff, Former Acting Commissioner of the FDA and Former Deputy Director of the National Center for Infectious Diseases at the CDC, joined the program to discuss the public awareness timeline of the cyclospora outbreak. The conversation highlighted that while the outbreak became widely known in early to mid-July, there were reports suggesting that government agencies had knowledge of the issue weeks prior to public disclosure. He speaks with Romaine Bostick on "The Close." (Source: Bloomberg)
Glass House Analysis
This story reflects the interconnected nature of modern economic systems, where developments in one sector inevitably affect others. Understanding these connections is essential for grasping how policy decisions and market movements translate into real-world outcomes for families, workers, and communities. The economy is not an abstract system of numbers—it's the sum total of decisions about who works, who prospers, and who struggles.
The implications extend beyond the immediate news cycle. Every economic development creates ripples that affect employment, prices, and opportunities in ways that may not be immediately visible but are deeply felt. By tracking these connections, we can better understand how the economy truly works—not as an abstract machine, but as a human system shaped by and shaping the lives of millions.
Enjoyed this analysis?
Get the Glass House Briefing every morning—market news that actually makes sense, delivered free to your inbox.
No spam. Unsubscribe anytime.
More Stories
‘I unexpectedly came into some money’: Is putting $20,000 into CDs a smart move?
“I want to make the process as straightforward as possible for my beneficiaries to access the funds.”
Lumentum sees sales more than double as AI demand swells
Though Lumentum posted blowout earnings and an upbeat forecast, its stock was largely flat after hours.
CoreWeave stock pops 13% as revenue doubles on accelerating AI infrastructure demand
CoreWeave's revenue is surging as the AI boom continues, but the company is also sitting on $35 billion in debt.
Asian Stocks to Slip With US CPI, Iran in Focus: Markets Wrap
Asian stocks were poised to follow Wall Street lower as traders held back from riskier bets ahead of key inflation data and remained wary over US-Iran developments.